Related Experiment Videos
Hematoporphyrin derivative photoradiation therapy in murine solid tumors
Cancer Letters
|December 1, 1983
Summary
Hematoporphyrin derivative (Hpd) photodynamic therapy shows promise for cancer treatment. This light-activated therapy effectively targets tumors, prolonging survival time in mice and potentially outperforming surgery for metastatic cancers.
Area of Science:
- Oncology
- Photochemistry
- Experimental Therapeutics
Background:
- Hematoporphyrin derivative (Hpd) is a photosensitizing agent investigated for its tumor-killing properties.
- Hpd preferentially accumulates in malignant tissues.
- Photosensitization by red light activates Hpd's cytocidal effects.
Purpose of the Study:
- To evaluate the efficacy of light-activated Hpd in treating experimental tumors.
- To compare photoradiation therapy (PRT) with surgical tumor excision.
Main Methods:
- Mice bearing MS-2 fibrosarcoma and B16 melanoma were treated with Hpd.
- Treatment involved external laser light or laser light delivered via fiber optic.
- Therapeutic outcomes were compared to surgical excision of primary tumors.
Main Results:
- Hpd photoradiation therapy significantly prolonged median survival time in tumor-bearing mice.
- Preliminary data suggest PRT is more effective than surgery for metastatic neoplasms.
Conclusions:
- Light-activated Hpd demonstrates significant cytocidal activity against experimental tumors.
- Photoradiation therapy presents a promising alternative to surgery, particularly for metastatic cancers.